KESTRA MEDICAL TECHNOLOGIES, LTD.
StreetZero Signal 62
About KESTRA MEDICAL TECHNOLOGIES, LTD.
Kestra Medical Technologies develops wearable medical devices focused on cardiac monitoring and defibrillation, including the ASSURE system for patients at risk of sudden cardiac arrest. The company emphasizes non-invasive, patient-friendly solutions in the cardiac care space. It is headquartered in Kirkland, Washington and operates as a public company listed on NASDAQ.
LATEST FUNDINGRule 144
$1.2M
Announced 2026-10-28
EMPLOYEESโ
FOUNDEDโ
HQKirkland, WA, USA
Industry
Public Equity (NASDAQ)
Tags
Medical DevicesCardiac CarePublic Equity
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Completed $1.22M Rule 144 private placement
- Focuses on wearable defibrillator technology
- Public company on NASDAQ
- Headquartered in Kirkland, Washington
Ask StreetZero about KESTRA MEDICAL TECHNOLOGIES, LTD.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account